Phone (336) 292-1510
Fax (336) 292-0679

Receive our eNewsletter

  Home  
  Our Team  
  Patient Info  
  Services  

News for Healthier Living

Popular Diabetes and Weight-Loss Drug May Reduce Risk of Dementia

Researchers at the Case Western Reserve School of Medicine have found that semaglutide, a popular diabetes and weight-loss drug, may lower the risk of dementia in people with type 2 diabetes (T2D). The study, published today in the Journal of Alzheimer's Disease (DOI 10.1177/13872877251351329), suggests T2D patients taking semaglutide had a significantly lower risk of developing dementia compared to other antidiabetic medications. These results were more profound in women and older adults.

June 24, 2025


June 24 2025

June 23 2025

June 22 2025

June 21 2025

June 20 2025

June 19 2025

June 18 2025

June 17 2025

June 16 2025

June 15 2025

June 14 2025

June 13 2025

June 12 2025

June 11 2025

June 10 2025